Clinical Trials Browser

Phase 2 × Neutropenia × trilaciclib × Clear all

NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

Phase 2 Recruiting

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma